Business Description
Pharvaris NV
ISIN : NL00150005Y4
Share Class Description:
PHVS: Ordinary SharesDescription
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2605.59 | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -38.4 | |||||
| 3-Year EPS without NRI Growth Rate | -41.1 | |||||
| 3-Year FCF Growth Rate | -45.5 | |||||
| 3-Year Book Growth Rate | 28 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -3.97 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.01 | |||||
| 9-Day RSI | 43.38 | |||||
| 14-Day RSI | 43.55 | |||||
| 6-1 Month Momentum % | 22.67 | |||||
| 12-1 Month Momentum % | -17.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.07 | |||||
| Quick Ratio | 19.07 | |||||
| Cash Ratio | 18.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.7 | |||||
| Shareholder Yield % | -29.92 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -43.51 | |||||
| ROA % | -41.22 | |||||
| ROIC % | -3037.06 | |||||
| ROC (Joel Greenblatt) % | -26479.12 | |||||
| ROCE % | -42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.1 | |||||
| Price-to-Tangible-Book | 3.1 | |||||
| EV-to-EBIT | -5.08 | |||||
| EV-to-Forward-EBIT | -3.79 | |||||
| EV-to-EBITDA | -5.09 | |||||
| EV-to-FCF | -5.93 | |||||
| Price-to-Net-Current-Asset-Value | 3.11 | |||||
| Price-to-Net-Cash | 3.19 | |||||
| Earnings Yield (Greenblatt) % | -19.69 | |||||
| FCF Yield % | -11.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PHVS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Pharvaris NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.843 | ||
| Beta | -3.41 | ||
| Volatility % | 83.11 | ||
| 14-Day RSI | 43.55 | ||
| 14-Day ATR ($) | 1.371611 | ||
| 20-Day SMA ($) | 19.57225 | ||
| 12-1 Month Momentum % | -17.2 | ||
| 52-Week Range ($) | 15.37 - 33 | ||
| Shares Outstanding (Mil) | 54.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharvaris NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharvaris NV Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharvaris NV Frequently Asked Questions
What is Pharvaris NV(PHVS)'s stock price today?
The current price of PHVS is $18.83. The 52 week high of PHVS is $33.00 and 52 week low is $15.37.
When is next earnings date of Pharvaris NV(PHVS)?
The next earnings date of Pharvaris NV(PHVS) is 2025-04-10 Est..
Does Pharvaris NV(PHVS) pay dividends? If so, how much?
Pharvaris NV(PHVS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers